BDBM406402 2-(Rac-trans)-4-Hydroxy-3-((2-phenyloxazol-4-yl)methyl)chroman-7-yl)-N-((1-methylcyclopropyl)sulfonyl)benzamide::US10336733, Example 46::US10336733, Example 47

SMILES CC(C)(C)S(=O)(=O)NC(=O)c1ccccc1-c1ccc2[C@@H](O)[C@H](Cc3coc(n3)-c3ccccc3)COc2c1

InChI Key InChIKey=OBCZDOIYQSEIQP-UHFFFAOYSA-N

Data  2 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 406402   

TargetLeukotriene B4 receptor 1(Human)
Merk Sharp & Dohme

US Patent
LigandPNGBDBM406402(2-(Rac-trans)-4-Hydroxy-3-((2-phenyloxazol-4-yl)me...)
Affinity DataEC50:  15nMAssay Description:The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
Go to US Patent

TargetLeukotriene B4 receptor 1(Human)
Merk Sharp & Dohme

US Patent
LigandPNGBDBM406402(2-(Rac-trans)-4-Hydroxy-3-((2-phenyloxazol-4-yl)me...)
Affinity DataEC50:  75nMAssay Description:The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
Go to US Patent